Find a Clinical Trial
Filter
Collagen Urine Assay
Male
50-80
Recruiting now
Department of Urology
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
Relapsed or refractory myeloma
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
M23-362
Diffuse large B-cell lymphoma, Follicular lymphoma, Lymphomas (adult)
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Takeda footprint
Neonatal care
All genders
0-1
Recruiting now
Department of Obstetrics + Gynecology
HGB-210
Sickle cell anemia
All genders
2-50
Recruiting now
Department of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Cancer Center
Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
Diffuse large B-cell lymphoma
All genders
75+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
BoppliTM blood pressure monitoring
Neonatal care
All genders
0-18
Recruiting now
Department of Pediatrics
LYS228 Pharmacokinetics for Complicated UTI
Urinary tract infections
All genders
18-85
Recruiting now
Department of Urology
The Connection study
Premature babies, Premature birth
All genders
No minimum age
Recruiting now
Department of Obstetrics + Gynecology